Russian pharmaceutical manufacturer Pharmasyntez is preparing to enter the Afghan market after reaching an agreement with Afghanistan’s Ministry of Public Health to begin supplying medicines to the country, as Kabul faces growing challenges in securing reliable drug imports. The company said the first shipments are expected to arrive within the next two months, with supplies expected to include insulin, antibiotics, and medicines for cardiovascu…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.